MarketInOut Stock Screener Log In | Sign Up

Supriya Lifescience Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 15:54
Supriya Lifescience Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization65,879 mln
Float23.47 mln
Earnings Date11/13/2026

EPS

24.65
Exceptional

P / E

34.98
Overvalued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.82
Caution advised

Relative Strength

66 / 100
Outperforming

Debt / Equity

0.01
Debt-free

Business Description

Founded in 1987 and based in Mumbai, India, Supriya Lifescience Limited researches, manufactures, and sells active pharmaceutical ingredients to customers around the world. The company serves a broad range of medical needs, supplying ingredients used in treatments for allergies, asthma, pain, high blood pressure, malaria, cancer, and several other conditions. Supriya also markets GelHeal, a wound care product, and Quickblue, a kit used to detect oral cancer. The company continues to develop new pharmaceutical compounds across a growing number of therapeutic areas, including diabetes, depression, antibiotics, and anti-cancer treatments.

Key Fundamentals

EPS24.65
P/E34.98
ROE18.16
RPS108
ROIC18.22
ROA16.18
Interest Cover148
EBITDA, mln3,008
EV / EBITDA26.09
EV / EBIT29.08
Revenue, mln8,725
EV / Revenue9.00

Quote Details

Last 862.25
Change 11.35 (1.33%)
Open 853.00
Volume 199,541
Turnover 172,054,224
Average Volume 209,140

Financial Ratios

Pre-Tax Profit Margin31
Current Ratio4.40
Price / Book6.38
Price / Tangible Book6.39
Price / Cash Flow117
Price / Free Cash Flow178
Debt / Equity0.01
Price / Sales8.76
PEG Ratio4.14

Financial Strength

Altman Z-Score32.5
Piotroski F-Score 4 / 9
Beneish M-Score-1.82
Price to Intrinsic Value6.48
Price to Lynch Fair Value4.01
Price to Graham Number3.22

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.33% 82 / 100   
1 Month -12.48% 27 / 100   
2 Months -0.04% 71 / 100   
6 Months 22.55% 83 / 100   
1 Year 16.88% 81 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog